Tag: renal impairment

Novo’s oral semaglutide hits targets in diabetics with renal impairment

by Selina McKee | Aug 21, 2018 | News | 0

Novo Nordisk says trial data show an oral formulation of its GLP-1 analogue semaglutide provided superior HbA1c and weight reductions versus placebo in people with type II diabetes and renal impairment.

Europe expands use of diabetes drug Xultophy

by Selina McKee | Sep 5, 2016 | News | 0

The European Commission has approved the expanded use of Novo Nordisk’s once-daily jab Xultophy in adults with type II diabetes and moderate renal impairment.